The Interplay between Circulating Tumor Cells and the Immune System: From Immune Escape to Cancer Immunotherapy

被引:61
作者
Leone, Kevin [1 ]
Poggiana, Cristina [1 ]
Zamarchi, Rita [1 ]
机构
[1] Veneto Inst Oncol IOV IRCCS, Padua, Italy
关键词
circulating tumor cells; immune system; immunotherapy; cancer biomarkers; liquid biopsy; metastasis; EPITHELIAL-MESENCHYMAL TRANSITION; NEUTROPHIL EXTRACELLULAR TRAPS; METASTATIC BREAST-CANCER; PLASMACYTOID DENDRITIC CELLS; REGULATORY T-CELLS; MONOCLONAL-ANTIBODY THERAPY; FACILITATE LUNG METASTASIS; GR-1+CD11B+ MYELOID CELLS; NATURAL-KILLER-CELLS; COLORECTAL-CANCER;
D O I
10.3390/diagnostics8030059
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Circulating tumor cells (CTCs) have aroused increasing interest not only in mechanistic studies of metastasis, but also for translational applications, such as patient monitoring, treatment choice, and treatment change due to tumor resistance. In this review, we will assess the state of the art about the study of the interactions between CTCs and the immune system. We intend to analyze the impact that the cells of the immune system have in limiting or promoting the metastatic capability of CTCs. To this purpose, we will examine studies that correlate CTCs, immune cells, and patient prognosis, and we will also discuss relevant animal models that have contributed to the understanding of the mechanisms of immune-mediated metastasis. We will then consider some studies in which CTCs seem to play a promising role in monitoring cancer patients during immunotherapy regimens. We believe that, from an accurate and profound knowledge of the interactions between CTCs and the immune system, new immunotherapeutic strategies against cancer might emerge in the future.
引用
收藏
页数:46
相关论文
共 258 条
[1]   Sequential Tracking of PD-L1 Expression and RAD50 Induction in Circulating Tumor and Stromal Cells of Lung Cancer Patients Undergoing Radiotherapy [J].
Adams, Daniel L. ;
Adams, Diane K. ;
He, Jianzhong ;
Kalhor, Neda ;
Zhang, Ming ;
Xu, Ting ;
Gao, Hui ;
Reuben, James M. ;
Qiao, Yawei ;
Komaki, Ritsuko ;
Liao, Zhongxing ;
Edelman, Martin J. ;
Tang, Cha-Mei ;
Lin, Steven H. .
CLINICAL CANCER RESEARCH, 2017, 23 (19) :5948-5958
[2]   Circulating Cancer-Associated Macrophage-Like Cells Differentiate Malignant Breast Cancer and Benign Breast Conditions [J].
Adams, Daniel L. ;
Adams, Diane K. ;
Alpaugh, R. Katherine ;
Cristofanilli, Massimo ;
Martin, Stuart S. ;
Chumsri, Saranya ;
Tang, Cha-Mei ;
Marks, Jeffrey R. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (07) :1037-1042
[3]   Circulating giant macrophages as a potential biomarker of solid tumors [J].
Adams, Daniel L. ;
Martin, Stuart S. ;
Alpaugh, R. Katherine ;
Charpentier, Monica ;
Tsai, Susan ;
Bergan, Raymond C. ;
Ogden, Irene M. ;
Catalona, William ;
Chumsri, Saranya ;
Tang, Cha-Mei ;
Cristofanilli, Massimo .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (09) :3514-3519
[4]   Epithelial-to-Mesenchymal Transition and Autophagy Induction in Breast Carcinoma Promote Escape from T-cell-Mediated Lysis [J].
Akalay, Intissar ;
Janji, Bassam ;
Hasmim, Meriem ;
Noman, Muhammad Zaeem ;
Andre, Fabrice ;
De Cremoux, Patricia ;
Bertheau, Philippe ;
Badoual, Cecile ;
Vielh, Philippe ;
Larsen, Annette K. ;
Sabbah, Michele ;
Tan, Tuan Zea ;
Keira, Joan Herr ;
Hung, Nicole Tsang Ying ;
Thiery, Jean Paul ;
Mami-Chouaib, Fathia ;
Chouaib, Salem .
CANCER RESEARCH, 2013, 73 (08) :2418-2427
[5]   PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome [J].
Alsaab, Hashem O. ;
Sau, Samaresh ;
Alzhrani, Rami ;
Tatiparti, Katyayani ;
Bhise, Ketki ;
Kashaw, Sushil K. ;
Iyer, Arun K. .
FRONTIERS IN PHARMACOLOGY, 2017, 8
[6]   Circulating and Disseminated Tumor Cells in the Clinical Management of Breast Cancer Patients: Unanswered Questions [J].
Amadori, A. ;
Rossi, E. ;
Zamarchi, R. ;
Carli, P. ;
Pastorelli, D. ;
Jirillo, A. .
ONCOLOGY, 2009, 76 (06) :375-386
[7]   Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients [J].
Anantharaman, Archana ;
Friedlander, Terence ;
Lu, David ;
Krupa, Rachel ;
Premasekharan, Gayatri ;
Hough, Jeffrey ;
Edwards, Matthew ;
Paz, Rosa ;
Lindquist, Karla ;
Graf, Ryon ;
Jendrisak, Adam ;
Louw, Jessica ;
Dugan, Lyndsey ;
Baird, Sarah ;
Wang, Yipeng ;
Dittamore, Ryan ;
Paris, Pamela L. .
BMC CANCER, 2016, 16
[8]   Toward a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multicenter study (CTCTrap) [J].
Andree, Kiki C. ;
Mentink, Anouk ;
Zeune, Leonie L. ;
Terstappen, Leon W. M. M. ;
Stoecklein, Nikolas H. ;
Neves, Rui P. ;
Driemel, Christiane ;
Lampignano, Rita ;
Yang, Liwen ;
Neubauer, Hans ;
Fehm, Tanja ;
Fischer, Johannes C. ;
Rossi, Elisabetta ;
Manicone, Mariangela ;
Basso, Umberto ;
Marson, Piero ;
Zamarchi, Rita ;
Loriot, Yohann ;
Lapierre, Valerie ;
Faugeroux, Vincent ;
Oulhen, Marianne ;
Farace, Francoise ;
Fowler, Gemma ;
Fontes, Mariane Sousa ;
Ebbs, Berni ;
Lambros, Maryou ;
Crespo, Mateus ;
Flohr, Penny ;
de Bono, Johann S. .
INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (10) :2584-2591
[9]  
[Anonymous], 2017, ANN ONCOL, DOI DOI 10.1093/ANNONC/MDX363.033
[10]   Portal Venous Blood Circulation Supports Immunosuppressive Environment and Pancreatic Cancer Circulating Tumor Cell Activation [J].
Arnoletti, Juan Pablo ;
Zhu, Xiang ;
Almodovar, Alvin J. O. ;
Veldhuis, Paula P. ;
Sause, Ryan ;
Griffith, Elizabeth ;
Corpus, George ;
Chang, Jeffrey C. C. ;
Fanaian, Na'im ;
Litherland, Sally A. .
PANCREAS, 2017, 46 (01) :116-123